Guerbet signs an agreement with Kyuan in China
Guerbet signs agreement with Kyuan for promotion & distribution of Lipiodol® Ultra-Fluid in China
Guerbet announced today the signing of an agreement with Beijing Kyuan Pharmaceutical Co., Ltd., one of the major pharmaceutical drugs distributors & importers in the Chinese market, to distribute & commercialize Lipiodol® Ultra-Fluid as from September 2015.
This agreement enables Guerbet flagship Interventional Radiology agent to benefit from Kyuan’s outstanding experience in distributing pharmaceuticals on the hospital market.
Read the press release
Follow all Guerbet's news on social media ӏ ӏ ӏ ӏ